Relevance to NICE guidance programmes
The use of the Cellvizio system is not currently planned into any NICE guidance programme.
NICE has issued the following guidance which is relevant to this briefing:
Suspected cancer: recognition and referral (2015) NICE guideline NG12
The SpyGlass direct visualisation system for diagnostic and therapeutic procedures during endoscopy of the biliary system (2015) NICE medtech innovation briefing 21
Suspected cancer recognition and referral (2015) NICE pathway
Pancreatic cancer, NICE guideline. Publication expected January 2018